Korro Bio, Inc. (KRRO NASDAQ) stock market data APIs
$10.7478
-0.23(-2.1%)
as of August 3, 2026
Try our APIs with
free plan!
Korro Bio, Inc. Financial Data Overview
Price chart is built with
Anychart
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Prev. Close
10.7478
Open
10.5203
High
10.9536
Low
10.2905
52 wk Range
5.2044-55.89
Market Cap
150 M
Shares Outstanding
14 423 K
Revenue
3 842 K
EPS
-1.69
Beta
2.106
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Korro Bio, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Korro Bio, Inc. data using free add-ons & libraries
Get Korro Bio, Inc. Fundamental Data
Korro Bio, Inc. Fundamental data includes:
- Net Revenue: 3 842 K
- EBITDA: -79 323 000
- Earnings Per Share: -11
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -1.982
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Korro Bio, Inc. News
New
Strength Seen in Ono Pharmaceutical Co. (OPHLF): Can Its 9.2% Jump Turn into More Strength?
Ono Pharmaceutical Co. (OPHLF) shares rallied 9.2% in the last trading session to close at $14.61. This move can be attributable to notable volume with a higher number of shares being traded than in a...
Korro Bio, Inc. (KRRO) Soars 17.6%: Is Further Upside Left in the Stock?
Korro Bio, Inc. (KRRO) shares ended the last trading session 17.6% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. Th...
Junevity Partners with Sunrise BioVentures as Advisors to Accelerate siRNA Therapeutic Development
Industry veterans from Sunrise BioVentures to provide strategic and operational support as the company advances its JUN_01 siRNA cardiometabolism program toward Phase 1 clinical trials and progresses ...
Top 5 Insider Buys From Q1: Buy, Sell, or Hold in Q2?
Colorful stock market chart with rising and falling lines behind bold “Insider Trades” text, symbolizing investor activity and insider buying trends. Key Points Insiders were active in Q1, but i...
Get Korro Bio, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
